31.25 USD
↘ 0.93 (2.88%)PRE MARKET (AS OF 05:22 AM EDT)
Zenas BioPharma, Inc. Common Stock
ZBIONASDAQ • USD
Market: OPEN
Zenas BioPharma, Inc. Common Stock (ZBIO) trades at $31.25 per share. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. ZBIO is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Aug 6, 2026.
Open?$32.19
High?$32.19
Low?$31.25
Prev. Close?$32.17
Volume?208
Avg. Volume?982.9K
VWAP?$32.18
Rel. Volume?0.00x
Bid / Ask
Bid?$25.86 × 100
Ask?$37.25 × 100
Spread?$11.39
Midpoint?$31.56
Valuation & Ratios
Market Cap?2.0B
Shares Out?63.1M
Float?29.1M
Float %?46.2%
P/E Ratio?N/A
P/B Ratio?6.05
EPS?-$6.73
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The Company manages its operations on a consolidated basis as a single reportable segment focused on the research, development and commercialization of transformative immunology-based therapies.
Employees
167
Market Cap
2.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-09-13
Address
852 WINTER STREET, SUITE 250
WALTHAM, MA 02451
Phone: 857-271-2954
WALTHAM, MA 02451
Phone: 857-271-2954
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?6
Momentum?50
Short Sent.?10
Piotroski F-Score?0/9Weak
Altman Z-Score?0.58Distress
Confidence?58%Low
Short InterestSqueeze Risk
Short % of Float?41.75%Squeeze Risk
Short Interest?12.2M
Days to Cover?12.5
Free Float29.1M
Avg Daily Volume976.9K
Settlement Date2026-07-15
Financial Health
Current Ratio?11.94Strong
Quick Ratio?11.94Strong
Cash Ratio?8.18Strong
Debt/Equity?0.79Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?6.05FAIR▾
Peers100
S&P30
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-4.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-126.6%WEAK▾
S&P3
ROA?-56.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-210480000
Enterprise Value?$1.8B
Fundamentals ratios updated end of day